We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTC
1401
LTC Properties
LTC
$2.16B
| $329K | ﹤0.01% |
8,972
+2,607
| +41% | +$94.5K |
|
1402
Rocket Pharmaceuticals
RCKT
$348M
| $329K | ﹤0.01% |
17,812
+3,802
| +27% | +$77.9K |
|
1403
Tronox
TROX
$995M
| $328K | ﹤0.01% |
22,449
+6,757
| +43% | +$96.3K |
|
1404
Knowles
KN
$3.22B
| $328K | ﹤0.01% |
18,176
+4,483
| +33% | +$79.5K |
|
1405
Landstar System
LSTR
$6.8B
| $328K | ﹤0.01% |
1,735
-141
| -8% | -$26K |
|
1406
IonQ
IONQ
$12.3B
| $328K | ﹤0.01% |
37,490
+15,552
| +71% | +$119K |
|
|
RVNC
1407
DELISTED
Revance Therapeutics, Inc.
RVNC
| $327K | ﹤0.01% |
63,097
+44,940
| +248% | +$223K |
|
1408
Kinetik
KNTK
$3.71B
| $327K | ﹤0.01% |
7,229
+2,350
| +48% | +$102K |
|
1409
Ultragenyx Pharmaceutical
RARE
$2.65B
| $327K | ﹤0.01% |
5,885
-5,257
| -47% | -$268K |
|
1410
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $327K | ﹤0.01% |
3,336
-272
| -8% | -$25K |
|
1411
The Greenbrier Companies
GBX
$1.61B
| $326K | ﹤0.01% |
6,411
+1,697
| +36% | +$80.9K |
|
1412
Middleby
MIDD
$6.05B
| $326K | ﹤0.01% |
2,344
-191
| -8% | -$25.7K |
|
1413
National Healthcare
NHC
$3.53B
| $326K | ﹤0.01% |
2,591
+647
| +33% | +$81.4K |
|
1414
National Bank Holdings
NBHC
$1.93B
| $325K | ﹤0.01% |
7,720
+2,028
| +36% | +$84.4K |
|
|
CALY
1415
Callaway Golf Company
CALY
$3.26B
| $325K | ﹤0.01% |
29,585
+7,474
| +34% | +$94K |
|
1416
Range Resources
RRC
$9.11B
| $325K | ﹤0.01% |
10,553
-889
| -8% | -$27.5K |
|
1417
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $324K | ﹤0.01% |
8,791
+2,285
| +35% | +$84.5K |
|
1418
Federal Agricultural Mortgage
AGM
$2.27B
| $324K | ﹤0.01% |
1,729
+505
| +41% | +$96.4K |
|
|
ELME
1419
Elme Communities
ELME
$132M
| $323K | ﹤0.01% |
18,362
+4,825
| +36% | +$82K |
|
1420
First Industrial Realty Trust
FR
$8.88B
| $323K | ﹤0.01% |
5,769
-472
| -8% | -$25.4K |
|
1421
PagerDuty
PD
$700M
| $322K | ﹤0.01% |
17,384
+5,424
| +45% | +$106K |
|
1422
Ingevity
NGVT
$2.55B
| $322K | ﹤0.01% |
8,263
+2,027
| +33% | +$80.7K |
|
1423
Sixth Street Specialty
TSLX
$1.59B
| $320K | ﹤0.01% |
15,597
+611
| +4% | +$12.8K |
|
|
STR
1424
DELISTED
Sitio Royalties
STR
| $318K | ﹤0.01% |
15,261
+4,243
| +39% | +$96.1K |
|
1425
Prospect Capital
PSEC
$1.06B
| $316K | ﹤0.01% |
59,082
+9,873
| +20% | +$52.4K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.